Founded in 2018, Seattle-based Alpenglow Biosciences is a privately held, early-stage life sciences company focused on accelerating drug development and improving clinical diagnostics with AI-enabled, 3D imaging technology. Our platform solution provides new spatial biology insights with greater accuracy by digitizing entire tissues while keeping samples intact for additional analysis. Alpenglow partners with pharmaceutical companies to develop better therapeutics and greater understanding of biodistribution, mechanism of action, and rank ordering of potential candidates using our patented technology. Five of the top 10 pharma companies work with Alpenglow to accelerate development timelines, gain new insights, and improve therapeutic success.

3D Technology

Health Care

Life Sciences

Alpenglow Biosciences

Nicholas Reder

Steve Pemberton

Alex Springer

Cody Cooper

Caleb Stoltzfus

The Research Team at Alpenglow Biosciences is responsible for advancing the company’s AI-enabled 3D imaging technology to enhance spatial biology insights. Comprising experts in research and development, the team conducts innovative studies to digitize tissues for better drug development and clinical diagnostics. They collaborate closely with pharmaceutical partners to explore biodistribution and therapeutic mechanisms, ultimately aiming to accelerate development timelines and improve candidate success rates.

Research Team

Engineering Team

Leadership Team

Research Team

About

Team members

Other teams at Alpenglow Biosciences

Engineering Team

Leadership Team